论文信息 - The Evolving Use of Biochemical Markers in the Management of Primary Biliary Cholangitis: Discussion. - 字舞流文

The Evolving Use of Biochemical Markers in the Management of Primary Biliary Cholangitis: Discussion.

P218]? Gut. 2021;70(suppl 1).

K. Kowdley | G. Hirschfield | D. Jones

[1] F. Nevens,et al. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool , 2020, European journal of gastroenterology & hepatology.

[2] G. Mells,et al. PS-009-Proteome of primary biliary cholangitis in naïve and UDCA treatment patients , 2019, Journal of Hepatology.

[3] G. Alexander,et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines , 2018, Gut.

[4] G. Hirschfield,et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.

[5] A. Burroughs,et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.

[6] M. Dumont,et al. European Association for the Study of the Liver , 1971 .